Zurich Cantonal Bank’s CollPlant Biotechnologies CLGN Stock Holding History

Zurich Cantonal Bank’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,309	Closed	-$148K	–	2712
2023 Q4	$148K	Sell	2,309 -5	-0.2%	-$274	﹤0.01%	2252
2023 Q3	$130K	Sell	2,314 -3	-0.1%	-$198	﹤0.01%	2224
2023 Q2	$188K	Buy	2,317 +5	+0.2%	+$364	﹤0.01%	1972
2023 Q1	$162K	Sell	2,312 -7	-0.3%	-$687	﹤0.01%	2012
2022 Q4	$194K	Hold	2,319	–	–	﹤0.01%	1840
2022 Q3	$159K	Sell	2,319 -2	-0.1%	-$162	﹤0.01%	1894
2022 Q2	$189K	Buy	+2,321	New	+$213K	﹤0.01%	1819
2022 Q1	–	Sell	-2,462	Closed	-$403K	–	2737
2021 Q4	$403K	Buy	+2,462	New	+$439K	﹤0.01%	1619

Other funds holding CLGN

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BFEC

Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Zurich Cantonal Bank's CLGN Position: Q1 2024 in Review

Zurich Cantonal Bank sold out of CollPlant Biotechnologies (CLGN) in Q1 2024, closing a stake of 2,309 shares — an estimated $148K sold.

Zurich Cantonal Bank first reported a position in CLGN in Q4 2021 and held it in 8 quarters. The position peaked at $403K in Q4 2021. 12 funds tracked by Wall St. Rank hold CLGN as of Q1 2024.

Zurich Cantonal Bank reported no remaining CollPlant Biotechnologies position as of Q1 2024 after selling out during the quarter.
Zurich Cantonal Bank sold 2,309 CollPlant Biotechnologies shares in Q1 2024, an estimated $148K.
Zurich Cantonal Bank first reported a position in CollPlant Biotechnologies in Q4 2021 and held it in 8 quarters.
Zurich Cantonal Bank's CollPlant Biotechnologies position peaked at $403K in Q4 2021.
12 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q1 2024.

Based on Zurich Cantonal Bank's 13F filing for Q1 2024, filed 25 Apr 2024.